Atlas Trials

A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects

Clinical trial NCT02742935 · COMPLETED

Trial details

NCT number
NCT02742935
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid TumorBreast CancerGastrointestinal Cancer
Start date
2016-04-27
Primary completion
2019-05-06
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.